15-48613055-A-T

Variant summary

Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate

The ENST00000316623.10(FBN1):​c.202T>A​(p.Cys68Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C68R) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

FBN1
ENST00000316623.10 missense

Scores

10
6
1

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 8.60
Variant links:
Genes affected
FBN1 (HGNC:3603): (fibrillin 1) This gene encodes a member of the fibrillin family of proteins. The encoded preproprotein is proteolytically processed to generate two proteins including the extracellular matrix component fibrillin-1 and the protein hormone asprosin. Fibrillin-1 is an extracellular matrix glycoprotein that serves as a structural component of calcium-binding microfibrils. These microfibrils provide force-bearing structural support in elastic and nonelastic connective tissue throughout the body. Asprosin, secreted by white adipose tissue, has been shown to regulate glucose homeostasis. Mutations in this gene are associated with Marfan syndrome and the related MASS phenotype, as well as ectopia lentis syndrome, Weill-Marchesani syndrome, Shprintzen-Goldberg syndrome and neonatal progeroid syndrome. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 13 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 7 uncertain in ENST00000316623.10
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr15-48613054-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 649153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), FBN1. . Gene score misZ 5.0644 (greater than the threshold 3.09). Trascript score misZ 8.1787 (greater than threshold 3.09). GenCC has associacion of gene with MASS syndrome, Weill-Marchesani syndrome, geleophysic dysplasia, Shprintzen-Goldberg syndrome, Acromicric dysplasia, familial thoracic aortic aneurysm and aortic dissection, progeroid and marfanoid aspect-lipodystrophy syndrome, ectopia lentis 1, isolated, autosomal dominant, Marfan syndrome, Weill-Marchesani syndrome 2, dominant, isolated ectopia lentis, neonatal Marfan syndrome, stiff skin syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.948
PP5
Variant 15-48613055-A-T is Pathogenic according to our data. Variant chr15-48613055-A-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 520234.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr15-48613055-A-T is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FBN1NM_000138.5 linkuse as main transcriptc.202T>A p.Cys68Ser missense_variant 3/66 ENST00000316623.10 NP_000129.3
FBN1NM_001406716.1 linkuse as main transcriptc.202T>A p.Cys68Ser missense_variant 2/65 NP_001393645.1
FBN1NM_001406717.1 linkuse as main transcriptc.202T>A p.Cys68Ser missense_variant 3/9 NP_001393646.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FBN1ENST00000316623.10 linkuse as main transcriptc.202T>A p.Cys68Ser missense_variant 3/661 NM_000138.5 ENSP00000325527 P1
FBN1ENST00000559133.6 linkuse as main transcriptc.202T>A p.Cys68Ser missense_variant, NMD_transcript_variant 3/671 ENSP00000453958
FBN1ENST00000674301.2 linkuse as main transcriptc.202T>A p.Cys68Ser missense_variant, NMD_transcript_variant 3/68 ENSP00000501333
FBN1ENST00000537463.6 linkuse as main transcriptc.202T>A p.Cys68Ser missense_variant, NMD_transcript_variant 3/315 ENSP00000440294

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsSep 17, 2015The p.C68S variant (also known as c.202T>A), located in coding exon 2 of the FBN1 gene, results from a T to A substitution at nucleotide position 202. The cysteine at codon 68 is replaced by serine, an amino acid with dissimilar properties. In one study, this variant was detected in an individual with classicalMarfansyndrome, and it was ade novooccurrence (Stheneuret al.Eur J Hum Genet.2009;17(9):1121-1128). In addition, c.203G>C, another variant that results in the same p.C68S substitution in thiscysteine-richregion, was detected in an individual withectopialentis, minor skeletal system involvement and skin involvement (ComeglioP et al.HumMutat.2007;28(9):928). An alteration at the same amino acid position, p.C68F (also known as c.203G>T), was also reported in a Chinese patient presented with ectopia lentis, myopia, atrial septal defect, mild mitral valve regurgitation, pectuscarinatum, arachnodactyly and dental crowding (Jin C et al, Mol. Vis. 2007 ; 13():1280-4).This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6493 samples (12986 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Pathogenic
0.36
CADD
Pathogenic
29
DANN
Uncertain
0.99
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D
M_CAP
Pathogenic
0.35
D
MetaRNN
Pathogenic
0.95
D
MetaSVM
Uncertain
0.073
D
MutationTaster
Benign
1.0
D
PrimateAI
Pathogenic
0.87
D
PROVEAN
Pathogenic
-7.1
D
REVEL
Pathogenic
0.82
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0040
D
Vest4
0.94
MutPred
0.80
Gain of ubiquitination at K72 (P = 0.068);
MVP
0.97
MPC
1.6
ClinPred
1.0
D
GERP RS
5.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs113604459; hg19: chr15-48905252; API